About: Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
Creator	Brugts, Jasper Daemen, Joost Gp Tijssen, Jan Mcfadden, Eugene Ren, Ben Spitzer, Ernest Van Mieghem, Nicolas
source	Medline; PMC
abstract	The coronavirus disease 2019 (COVID-19) pandemic started in Wuhan, Hubei Province, China, in December 2019, and by 24 April 2020, it had affected >2.73 million people in 185 countries and caused >192,000 deaths. Despite diverse societal measures to reduce transmission of the severe acute respiratory syndrome coronavirus 2, such as implementing social distancing, quarantine, curfews and total lockdowns, its control remains challenging. Healthcare practitioners are at the frontline of defence against the virus, with increasing institutional and governmental supports. Nevertheless, new or ongoing clinical trials, not related to the disease itself, remain important for the development of new therapies, and require interactions among patients, clinicians and research personnel, which is challenging, given isolation measures. In this article, the authors summarise the acute effects and consequences of the COVID-19 pandemic on current cardiovascular trials.
has issue date	2020-05-01(xsd:dateTime)
bibo:doi	10.15420/cfr.2020.07
bibo:pmid	32411396
has license	cc-by-nc
sha1sum (hex)	12a1c1aade00c735f4e84a59a02a25c33876e2d6
schema:url	https://doi.org/10.15420/cfr.2020.07
resource representing a document's title	Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
has PubMed Central identifier	PMC7215493
has PubMed identifier	32411396
schema:publication	Card Fail Rev
resource representing a document's body	covid:12a1c1aade00c735f4e84a59a02a25c33876e2d6#body_text
is schema:about of	named entity 'symptoms' named entity 'shortness' named entity 'caused' named entity 'decades' named entity 'outbreak' named entity 'civet cat' named entity 'camel' named entity 'Cardiovascular' named entity 'Coronavirus' named entity 'OUTBREAK' named entity 'PRIMARY' named entity 'SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2' covid:arg/12a1c1aade00c735f4e84a59a02a25c33876e2d6 named entity 'breath' named entity 'contained' named entity 'MERS-CoV' named entity 'Middle East respiratory syndrome' named entity 'reached' named entity 'China' named entity 'fever' named entity 'SARS-CoV-2' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'follow-up' named entity 'quality assurance' named entity 'intention-to-treat' named entity 'Clinical research' named entity 'self-isolate' named entity 'standard procedures' named entity 'safety monitoring' named entity 'safety monitoring' named entity 'confidentiality' named entity 'infectious diseases' named entity 'Statistical analysis' named entity 'cardiovascular' named entity 'STEMI' named entity 'clinical trial' named entity 'cardiac CT' named entity 'personal protective equipment' named entity 'biological products' named entity 'quality assurance' named entity 'COVID-19' named entity 'Highly contagious' named entity 'clinical trials' named entity 'cardiac MRI' named entity 'vaccines' named entity 'institutional review boards' named entity 'biostatistician' named entity 'patient safety' named entity 'regulatory agencies' named entity 'critical role' named entity 'myocarditis' named entity 'angiography' named entity 'ECG' named entity 'clinical research' named entity 'cardiovascular' named entity 'standard procedures' named entity 'drug trials' named entity 'data integrity' named entity 'Regulatory agencies' named entity 'standard procedures' named entity 'regulatory documents' named entity 'public transportation' named entity 'International Conference' named entity 'COVID-19' named entity 'international standards' named entity 'regulatory bodies' named entity 'angiography' named entity 'evidence-based treatments' named entity 'clinical trials' named entity 'Core laboratories' named entity 'non-STEMI' named entity 'regulatory agencies' named entity 'intensive care' named entity 'clinical trials' named entity 'healthcare professionals'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software